Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus.
AUTOR(ES)
Byron, M A
RESUMO
Fibrinolytic and other factors have been measured in 73 patients with systemic lupus erythematosus or related conditions to determine whether clinical thrombosis, a common feature of these disorders, is associated with defective fibrinolysis. Twenty five of 72 (35%) patients, compared with two of 22 (9%) controls, showed a low level of plasminogen activator activity in response to venous occlusion, suggesting decreased fibrinolytic potential. In addition, mean plasma levels of von Willebrand factor antigen and fibronectin were markedly raised in the patients (mean (SD) 384.5 (277)% and 727 (436) mg/l respectively) compared with healthy controls (100 (50)% and 306 (65) mg/l). These data suggest a degree of endothelial cell dysfunction. No clear correlation was found between a history of thrombosis and any plasma factor measured, except for prolongation of clotting tests suggestive of the 'lupus anticoagulant'.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003380Documentos Relacionados
- Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
- Endothelial inclusions and "nuclear bodies" in systemic lupus erythematosus.
- Peripheral vascular disease in patients with systemic lupus erythematosus.
- Anticardiolipin antibody negative occlusive vascular retinopathy in systemic lupus erythematosus.
- B cell lymphokines in human systemic lupus erythematosus.